Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Verity PharmaCI: Using Information to Stay Ahead of the Competition in Life Sciences
- Pharmaceutical and biotechnology companies are under pressure to bring drugs to market quicker. Thus there is a need to maximize their return on each new drug introduced to the market, to comply with stringent government regulations, to understand the impact of patent expiration on their drug portfolio and to rapidly...
- White papers 2005-06-29
- The Drug Industry's Alliance Archipelago
- Big pharmaceuticals have the money to fund the development and marketing of new drugs, but their R&D hit rate has not been sufficient to replace products coming off patent. Small biotechnology companies are awash in new technologies, but lack the cash to bring products through the expensive regulatory approval processes....
- White papers 2003-12-01
- Can You Capture & Value The Price Of Speed?: Outsourcing For Drug Development & Manufacturing
- Outsourcing drug research has become more popular, not only because of increased efficiencies in third-party core competencies, but also because numerous Pharmaceutical & Biotech companies are often challenged with conflicting budgets, dated equipment, software or knowledge that may or may not fall short of existing regulatory allowances. Emphasis has traditionally...
- White papers 2003-01-01
- A New Approach to Valuing Biotech Stocks
- Stocks of biotechnology companies are soaring. However, while these companies have promising technologies, they are years away from profits. The boomlet shows, however, how hard it is to value biotech stocks. Analysts often use proxy drivers such as the number of patents or the dollar value of partnerships to value...
- White papers 2001-02-11
Additional Resources
- Targeted Genetics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
- Targeted Genetics Corporation (NASDAQ: TGEN)announced today that H. Stewart Parker, President and Chief ExecutiveOfficer, will present a company overview at the Rodman & Renshaw 5th AnnualGlobal Healthcare Conference on Monday, May 19 at 9:20 a.m., Monte Carlo,Monaco. The presentation will be webcast live and available for replay from theTargeted Genetics...
- Articles 2008-05-08
- Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
- BRIDGEWATER, N.J. -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that its Board of Directors has authorized a plan to spin-off its novel biotechnology business from Enzon in a transaction that will result in two independent and highly focused public companies. "By separating these unique businesses into two...
- Articles 2008-05-07
- Enzon Reports Strong First Quarter 2008 Results
- BRIDGEWATER, N.J. -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced strong first quarter 2008 financial results. For the three months ended March 31, 2008, Enzon reported a net income of $1.5 million or $0.03 per diluted share, as compared to a net loss of $2.8 million or $0.06 per diluted...
- Articles 2008-05-07
- Annual Report 2007 Active Biotech AB (publ)
- Active Biotech's Annual Report 2007is now available for download at www.activebiotech.com . As from now, the Annual Report will only be digitally distributed. Lund, May 7, 2008 Active Biotech AB publ Sven AndréassonPresident & CEOFor further information, please contact:Cecilia HofvanderManager Corporate CommunicationTel +46 (0)46 19 11 22 Active Biotech...
- Articles 2008-05-07
- Acucela Files Investigational New Drug Application
- ---- Orally-available Small Molecule for Dry Form of AMD ---- BOTHELL, Wash. -- Acucela Inc., a clinical-stage biotechnology company focused on developing therapies for blinding eye diseases, announced today that it has filed an investigational new drug IND application to conduct a Phase 1 clinical trial for its...
- Articles 2008-05-07
- Cutting Edge Information Offers a Unique Collection of Primary Pharmaceutical Intelligence Reports
- Cutting Edge Information( www.CuttingEdgeInfo.com ), a competitive intelligence firm based out ofResearch Triangle Park, North Carolina, is pleased to extend an invitationto pharmaceutical, biotechnology, medical device and healthcare companiesto explore its collection of benchmarking reports. Jason Richardson, Cutting Edge Information's President and CEO, notes theinformation housed in the company's intelligence...
- Articles 2008-05-07
- Bio-Matrix Scientific Group, Inc. Installs Computype's Secured Blood Bank Labeling and Identification Systems for its Adult Stem Cell Processing and Cryogenic Banking Laboratories
- SAN DIEGO -- Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on adult stem cell processing and cryogenic storage, announced today that it is installing blood bank labeling systems manufactured by Computype in all of Bio-Matrix' laboratories. A major emphasis of Bio-Matrix' Quality Systems prior to acceptance...
- Articles 2008-05-07
- Synthetic Blood International, Inc. to Open New Research Office at Virginia BioTechnology Research Park
- COSTA MESA, Calif. -- Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that it has signed an agreement to lease space for a research office in the Virginia BioTechnology Research Park, located in Richmond, VA. This space will be used to coordinate research between the company and sponsored researchers...
- Articles 2008-05-07
- Verticals onDemand Signs 15th Life Sciences Customer, Marking the Dawn of an Industry-Wide Conversion from Client/Server to SaaS CRM Technology
- PLEASANTON, Calif. -- In the last nine months, fifteen life sciences companies have signed with Verticals onDemand, the pharmaceutical industry's only provider of Software-as-a-Service SaaS CRM solutions. Verticals onDemand's latest customer, UK-based ProStrakan Group plc (www.prostrakan-usa.com), selected VBioPharma shortly after establishing their U.S. division earlier this year. Verticals onDemand's client...
- Articles 2008-05-07
- InNexus Biotechnology Launches Competitive Summer Intern Program — LABapprentice
- BRITISH COLUMBIA, Canada -- InNexus Biotechnology Inc. (OTCBB: IXSBF) (TSX VENTURE: IXS) (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL[TM]) technology, begins LABapprentice, a competitive summer intern program with a twist, to reach internet surfers via the website: www.labapprentice.com....
- Articles 2008-05-07
- InNexus Biotechnology Receives 2008 Frost & Sullivan Innovation of the Year Award
- BRITISH COLUMBIA, Canada -- InNexus Biotechnology Inc. (OTCBB:IXSBF) (TSX VENTURE:IXS) (www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies, today announced that it has been awarded the 2008 Frost & Sullivan Therapeutic Monoclonal Antibodies Technology Innovation of the Year Award for its Dynamic Cross Linking (DXL[TM]) technology....
- Articles 2008-05-07
- WuXi PharmaTech Schedules First Quarter 2008 Earnings Release on Tuesday, May 27, 2008
- Earnings Conference Call to be held on May 28, 2008 at 8:00 am Eastern / 5:00 am Pacific / 8:00 pm (Beijing/Hong Kong) SHANGHAI, China, May 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech Cayman Inc. , a leading...
- Articles 2008-05-06
- Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
- ARLINGTON, Va., May 6 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (BULLETIN BOARD: CSBR) , a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, announced today the completion of a Service Agreement with Concordia Pharmaceuticals, Inc. and initiation...
- Articles 2008-05-06
- WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
- SHANGHAI, China, May 6 /Xinhua-PRNewswire/ -- WuXi PharmaTech Cayman Inc. , a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that it has postponed its proposed underwritten follow-on public offering. (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) ...
- Articles 2008-05-06
- Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference
- HAYWARD, Calif., May 6 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated announced today that Jane Green, Kosan's Vice President, Corporate Communications, will present at the Leerink Swann Solid Tumors Roundtable Conference in New York at the Grand Hyatt Hotel on Friday, May 9, 2008 at 11:10 a.m. EDT. A...
- Articles 2008-05-06
- AmberPoint Continues Record Market Traction with Marquee New Customers Across Industries and Geographies
- Leader in SOA Runtime Governance Grows Customer Roster with High-Profile New Accounts OAKLAND, Calif. -- AmberPoint announced today that it has significantly increased its market-leading customer roster with recent sales of its SOA runtime governance software. The company's enterprise customers around the globe now total well over 200....
- Articles 2008-05-06
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
